alexa
Reach Us +44-1474-556909
Shanmugam S | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

33rd World Congress on Pharmacology

Barcelona, Spain

7th European Biopharma Congress

Prague, Czech Republic
Share This Page

Shanmugam S

Project Leader, Hanmi Pharm. Co. Ltd.,korea

Biography

 Dr. Srinivasan Shanmugam received his Ph.D. in Pharmaceutical Science from the College of Pharmacy, Yeungnam University in 2010. During his doctoral studies, his research was on liposomes, niosomes, and chemical enhancers for topical delivery and self-emulsifying drug delivery systems (SNEDDS) for oral delivery. He received his MS in Pharmaceutical Sciences in the same university in the year of 2007, and his research focus during this period was on mixed micellar nanoparticles for parenteral and liposomes for topical delivery. His undergraduate major was Pharmacy (Bachelor of Phramacy) and received his degree in the year of 1999 with research focus on “Endothelin Receptors.” Right after undergraduate degree, he gained hands on experience in manufacturing of solid/liquid dosage formulations by working in pharmaceutical companies for about five years. Currently, Dr. Shanmugam is a Project Leader (Principal Scientist) in Formulation R&D Division of Hanmi Pharm. Co. Ltd., South Korea.

Research Interest

 Drug Delivery Systems:  Conventional systems (tablets, capsules, emulsions, and suspensions)  Novel delivery systems (lipid formulations, micro/nano emulsions/self-emulsifying, micelles, liposomes/niosomes/cubosomes, multiparticulate, and pulsatile/targeted delivery ssytems). Drug Delivery Techniques:  Dissolution/solubility/stability enhancement  Bioavailability enhancement (oral/lymphatic/transdermal)  Perrmeability enhancement (oral/topical/transdermal) Drug Delivery Technologies:  Modified release (sustained/delayed/controlled/pulsatile/targeted)  Spray/freeze drying, and fluid bed drying

Publications

Global Speakers in the subject

Global Experts in the subject

Top